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Background: Low birth weight and unhealthy lifestyles in adulthood have been independently associated with an
elevated risk of hypertension. However, no study has examined the joint effects of these factors on incidence
of hypertension.
Methods: We followed 52,114 women from the Nurses’ Health Study II without hypercholesterolemia, diabetes,
cardiovascular disease, cancer, prehypertension, and hypertension at baseline (1991–2011). Women born preterm,
of a multiple pregnancy, or who were missing birth weight data were excluded. Unhealthy adulthood lifestyle was
defined by compiling status scores of body mass index, physical activity, alcohol consumption, the Dietary
Approaches to Stop Hypertension diet, and the use of non-narcotic analgesics.
Results: We documented 12,588 incident cases of hypertension during 20 years of follow-up. The risk of
hypertension associated with a combination of low birth weight at term and unhealthy lifestyle factors (RR, 1.95;
95 % CI, 1.83–2.07) was more than the addition of the risk associated with each individual factor, indicating a
significant interaction on an additive scale (Pinteraction <0.001). The proportions of the association attributable to
lower term birth weight alone, unhealthy lifestyle alone, and their joint effect were 23.9 % (95 % CI, 16.6–31.2),
63.7 % (95 % CI, 60.4–66.9), and 12.5 % (95 % CI, 9.87–15.0), respectively. The population-attributable-risk for the
combined adulthood unhealthy lifestyle and low birth weight at term was 66.3 % (95 % CI, 56.9–74.0).
Conclusion: The majority of cases of hypertension could be prevented by the adoption of a healthier lifestyle,
though some cases may depend on simultaneous improvement of both prenatal and postnatal factors.
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Hypertension affects one third of American adults [1] and
is the leading cause of global disease burden [2, 3]. Pre-
natal factors, such as intrauterine nutrition status [4–11],
and adulthood factors, such as unhealthy diet and lifestyle
[12, 13], have been independently associated with an ele-
vated risk of hypertension. The association between pre-
natal famine exposure and high blood pressure was
consistently observed in studies of the Dutch famine [11],
the Leningrad Siege [10], and the Chinese famine [8]. In
addition, low birth weight has been consistently associated* Correspondence: frank.hu@channing.harvard.edu; nhlqi@channing.harvard.edu
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creativecommons.org/publicdomain/zero/1.0/with an increased risk of hypertension [4–6]. Compel-
ling evidence has also related adulthood lifestyle such as
body weight, diet, physical activity, and alcohol con-
sumption with the development of hypertension; life-
style modifications have been recommended for
prevention of hypertension [12, 13].
However, no previous study has examined the joint as-
sociations of birth weight and adulthood lifestyle with
hypertension risk, or evaluated their potential interac-
tions. In this study, we prospectively assessed the joint
association of birth weight at term – a marker of fetal
growth restriction – and established lifestyle risk factors
in adulthood with incident hypertension in the Nurses’
Health Study (NHS) II [14].distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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Study population
In 1989, 116,430 female registered nurses aged 25 to 42
years enrolled in NHS II by completing and returning an
initial questionnaire that provided detailed information
on medical history, lifestyle, and medications. The diet-
ary survey was initiated using a food frequency question-
naire (FFQ) in 1991, which served as the baseline of the
present analysis. Detailed information on lifestyle habits
and medical history was updated biennially; FFQ was
updated every 4 years. The follow-up for the cohort
exceeded 90 % of eligible person-time.
In 1991, 100,090 participants returned the questionnaire
including a FFQ. For the current analysis, we excluded
participants (1) who reported diagnosis of hypertension,
ever use of antihypertensive medication, or who reported
median systolic blood pressure in the prehypertensive
range, greater than 120 mmHg or diastolic blood pressure
greater than 80 mm Hg, at or before baseline of the
current analysis (1991, n = 18,468); (2) who reported phys-
ician diagnosis of other chronic conditions, including
hypercholesterolemia, diabetes, cardiovascular disease,
and cancer at baseline (n = 12,901); (3) who had missing
data on dietary, physical activity, alcohol consumption, use
of non-narcotic analgesics, or body weight at baseline (n =
6,904); and (4) who were born preterm (n = 4,339, defined
as ‘born 2+ weeks premature’), did not provide birth
weight data (n = 4,677), or who were born of a multiple
pregnancy (n = 687). After these exclusions, 52,114
women were included in the analysis. Participants who did
not report birth weight or missed lifestyle factors had simi-
lar age (mean 36.3 ± 4.7 vs 36.0 ± 4.7 years) and body
mass index (BMI; 24.9 ± 5.5 vs 24.6 ± 5.3 kg/m2) as those
with relative information.
The Institutional Review Boards at the Harvard School
of Public Health and Brigham and Women’s Hospital
approved the study protocol. The completion of the self-
administered questionnaire was considered to imply
informed consent.
Ascertainment of hypertension
The baseline and follow-up biennial questionnaires asked
participants to report whether a clinician had made a new
diagnosis of hypertension during the preceding 2 years
[14]. Self-reported hypertension was validated in a subset
of this cohort using medical record review [15]. Of 51
women who reported hypertension and for whom records
of blood pressure were available, the initial report was con-
firmed in all cases (blood pressure >140/90 mmHg). In a
second survey, blood pressure was measured in a sample
of Boston-area participants who were part of the diet valid-
ation study. Among the 161 participants sampled who did
not report high blood pressure, none had a blood pressure
greater than 160/95 mmHg and 6.8 % had values between140/90 and 160/95 mmHg. This confirms a low rate of
false negative reporting. Self-reported blood pressure and
hypertension are also strong predictors of coronary heart
disease in the NHS study [16]. Incident hypertension cases
included individuals who first reported hypertension on
questionnaires after 1991 [15].
Ascertainment of birth weight
Participants in NHS II were asked about their birth
weight on the 1991 questionnaires [14]. Five categories
of birth weight responses (in lb) were specified: <5.5,
5.5–6.9, 7.0–8.4, 8.5–9.9, ≥10.0 (in kg: <2.5, 2.5–3.15,
3.16–3.82, 3.83–4.49, ≥4.5). A validation study on birth
weight was reported previously [17]. In brief, the mean
values (in lb) for the five birth weight categories calcu-
lated with the state birth records of 220 randomly se-
lected NHS II participants were 4.8, 6.3, 7.6, 8.9, and
10.3 [17]. In addition, 70.0 % of the NHS II participants
reported the same birth weight category as was obtained
from state birth records [17]. The Spearman correlation
between self-reported birth weight and weights recorded
on state birth records was 0.74 (P <0.001) [17].
Definition of unhealthy and healthy lifestyle
Five lifestyle factors were included in our healthy lifestyle
score, namely diet, physical activity, alcohol consumption,
use of non-narcotic analgesics, and BMI, based on the
strength of evidence related to risk of hypertension [12].
For each lifestyle factor the participant received 1 if she
met the criteria for low risk, and 0 otherwise. This lifestyle
score predicted risk of hypertension in our previous study
in this cohort [12]. In sensitivity analysis, we also assigned
weights to each low-risk factor based on the beta coeffi-
cients from the multivariable-adjusted Cox model with in-
cident hypertension as the outcome. We then summed up
the products, divided it by the sum of all beta coefficient
values, and then multiplied by 5 to make the low-risk life-
style score easier to interpret, e.g. each unit of the ex-
panded low-risk lifestyle score presented one risk factor.
For physical activity, we classified low risk as ≥3.5
hours/week of moderate or vigorous activity. We defined
moderate alcohol consumption as greater than zero but
not exceeding 10 g/d (approximately 1 alcohol beverage
per day) for moderate alcohol intake. Low risk BMI was
defined as BMI <25 kg/m2. We calculated the dietary
score of the Dietary Approaches to Stop Hypertension
(DASH) diet, which has been associated with blood pres-
sure [18, 19]. Women with DASH scores in the top
quintile (20 %) were classified as having a low-risk diet.
The low-risk category of non-narcotic analgesic use was
defined as the use that was less frequent than once per
week, as previous studies have documented increases in
the risk of incident hypertension with even a low fre-
quency of non-narcotic analgesic use [20–22].
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We presented the baseline characteristics of the study
population according to the category of term birth
weight in Table 1. Values were means ± standard devi-
ation or percentages and were standardized to the age
distribution of the study population.
Individuals contributed person-time from the return of
the baseline questionnaire (1991) until the date of diag-
nosis of hypertension, diabetes, cardiovascular disease or
cancer, death, loss to follow-up, or the end of the follow-
up period (June 30, 2011), whichever came first.
Multivariable Cox proportional hazards models were
used to estimate relative risk (RR) and 95 % confidence
intervals (CIs) for the association between birth weight
at term and hypertension risk, with participants in the
middle category of birth weight at term (3.16–3.82 kg)
as the reference group. A linear trend across birth
weight categories was evaluated with a Wald test for lin-
ear trend by assigning the median value to each category
and modelling this variable as a continuous variable. We
adjusted for a priori potential confounders including
age, ethnicity, a family history of hypertension, smoking
status, supplemental folic acid intake, and oral contra-
ceptive use. We also adjusted the lifestyle factors includ-
ing alcohol consumption, physical activity, DASH score,
and the use of non-narcotic analgesics for theTable 1 Age-adjusted characteristics of participants according to ter
Term birth weight categ
<2.5 2.5
N (52,114) 1,763 15
Percentage, % 3.4 29
Age, years* 36.4 ± 4.6 35
Body mass index, kg/m2 23.3 ± 4.2 23
Total energy intake, kcal/d 1791 ± 565 17
DASH score 23.5 ± 5.1 23
Alcohol intake, g/d 2.9 ± 5.4 3.2
Current smoking, % 12.3 11
Moderate/vigorous intensity exercise, h/wk 2.5 ± 3.8 2.5
Family history of hypertension, % 51.5 48
White, % 93.5 93
Use of oral contraceptive pills, % 12.5 11
Use of supplemental folic acid, % 41.6 43
Supplemental folic acid intake, μg/d 147 ± 239 16
Nonnarcotic analgesic use at least once per week, %
Aspirin or aspirin-containing products 10.7 10
Ibuprofen 17.9 16
Acetaminophen 22.7 19
Values are means ± standard deviation (SD) or percentages and are standardized to
*Value is not age adjusted
DASH Dietary Approaches to Stop Hypertensionassociation between birth weight at term and hyperten-
sion. In a secondary analysis, we also further adjusted
for adult BMI. We ran separate models with and without
BMI because BMI may be confounder or mediator of
the association between birth weight and hypertension.
We updated information during follow-up period by
using the most recently available information.
Participants were also classified according to the joint
categories of birth weight at term and the number of un-
healthy lifestyle factors. Lifestyle factors were updated at
each questionnaire cycle to reflect the most recent infor-
mation as a time-varying variable. If data were missing at
a given time point, data from the previous cycle was used.
We defined the group with birth weight at term <2.5 kg
and with five unhealthy lifestyle scores as the reference
group (with the highest risk of hypertension) and used
multivariable Cox proportional hazards models to esti-
mate RRs. We evaluated whether the associations between
birth weight at term and hypertension differed by adult-
hood lifestyle on both multiplicative and additive scales
[23–25]. The multiplicative interaction was tested by com-
paring the –2 log likelihood of the multivariate-adjusted
models with and without the cross-product interaction
term [24].
To assess the additive interaction between birth weight
at term and unhealthy lifestyle on risk of hypertension,m birth weight category at baseline (1991)
ories (kg)
–3.15 3.16–3.82 3.83–4.49 ≥4.5
,346 27,253 7,064 688
.4 52.3 13.6 1.3
.6 ± 4.6 35.6 ± 4.6 35.1 ± 4.6 35.7 ± 4.5
.4 ± 4.3 23.6 ± 4.2 24.0 ± 4.4 24.6 ± 4.8
79 ± 746 1800 ± 539 1806 ± 543 1796 ± 558
.7 ± 5.1 23.9 ± 5.1 24.0 ± 5.1 24.1 ± 5.3
± 5.9 3.2 ± 5.8 3.0 ± 5.9 2.9 ± 5.2
.3 11.1 11.3 9.5
± 3.9 2.5 ± 3.9 2.5 ± 3.8 2.8 ± 4.8
.5 47.7 49.3 54.7
.2 95.5 96.0 94.3
.2 11.2 11.3 12.1
.0 43.3 42.9 44.1
0 ± 257 161 ± 258 166 ± 263 161 ± 248
.2 9.7 9.4 11.0
.9 16.4 16.3 17.7
.9 19.3 19.2 22.5
the age distribution of the study population
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unhealthy lifestyle factors as two continuous variables
and assessed the main effects on incident hypertension
per 1-kg lower birth weight at term (RRg1e0), per 1-point
higher unhealthy lifestyle score (RRg0e1), and their joint
effect (RRg1e1), as well as the Relative Excess Risk due to
Interaction (RERI), using the equation listed below as
given by VanderWeele [24–26]:
RERI ¼ e g1‐g0ð Þγ1þ e1‐e0ð Þγ2þ g1e1‐g0e0ð Þγ3–e g1‐g0ð Þγ1þ g1‐g0ð Þe0γ3
– e e1‐e0ð Þγ2þ e1‐e0ð Þg0γ3 þ 1
Where, g1 and g0 mean different levels of birth weight
at term while e1 and e0 mean different levels of un-
healthy lifestyle.
We further proceeded with the decomposition of the
joint effect, e.g. the proportions attributable to a lower term
birth weight alone as [(RRg1e0 – 1)/ (RRg1e1 – 1)], unhealthy
lifestyle alone as [(RRg0e1 – 1)/ (RRg1e1 – 1)], and to their
interaction using the equations as [RERI/(RRg1e1 – 1)], the
detail information on the equation has been previously
published [25, 26].
We also calculated the population-attributable risk
(PAR%) using the standard equation [27] as,
PAR ¼ RR‐1ð Þ  Pe½   RR‐1ð Þ  Pe½  þ 1f g
The estimated PAR% was the percentage of incident
hypertension in the study population that theoretically
would not have occurred if all people had been in the
low-risk group, combining a healthy birth weight at term
and a healthy lifestyle, assuming a causal relation be-
tween the risk factors and hypertension.
Data were analyzed using a commercially available
software program (SAS, version 9.3; SAS Institute, Inc.),
and statistical significance was set at a two-tailed
P <0.05.
Results
Table 1 presents the age-adjusted characteristics of the
participants according to the term birth weight categories.
The prevalence of the lifestyle variables at baseline was
similar across the categories of birth weight at term. Par-
ticipants with term birth weight <2.5 or ≥4.5 kg were more
likely to report a family history of hypertension. Women
who had higher birth weight at term tended to have a
higher adult BMI than women who were small at birth.
We documented 12,588 new cases of hypertension dur-
ing the 20 years of follow-up. We observed a consistent,
graded inverse association between birth weight at term
and risk of hypertension (Table 2). Compared to partici-
pants in the middle category of birth weight at term
(3.16–3.82 kg), the multivariate adjusted relative risk of
hypertension among people with the lowest birth weight
at term (<2.5 kg) was 1.25 (95 % CI, 1.14–1.37). Furtheradjustment for current BMI had no material impact on
the association between low birth weight at term and
hypertension, with a RR of 1.29 (95 % CI, 1.18–1.41).
We further classified the participants according to the
joint categories of birth weight at term and the unhealthy
lifestyle score, and defined the group with the highest risk
as the reference (birth weight at term of <2.5 kg and five
unhealthy lifestyle score). The graded decreasing risk of
hypertension with increasing of birth weight at term ap-
peared consistent across all levels of unhealthy lifestyle
factors (P for multiplicative interaction = 0.99, Fig. 1).
Compared to the reference group, the multivariate-
adjusted relative risk (RR) of hypertension was 0.13
(95 % CI, 0.09–0.18) among women with ≤1 unhealthy
lifestyle factors combined with birth weight at term of
3.83–4.49 kg.
The RRs of hypertension were 1.23 (95 % CI, 1.11–1.36)
per 1-kg lower birth weight at term and 1.61 (95 % CI,
1.51–1.71) per 1-point higher unhealthy lifestyle score. In
addition, we observed that the risk of hypertension associ-
ated with a combination of low birth weight at term and
unhealthy lifestyle factors (RR, 1.95; 95 % CI, 1.83–2.07)
was more than addition of the risk associated with each
individual factor, indicating a significant interaction on an
additive scale (P for additive interaction <0.0001; Table 3).
The proportions of the association attributable to low
birth weight alone, unhealthy lifestyle alone, and their joint
effect were 23.9 % (95 % CI, 16.6–31.2), 63.7 % (95 % CI,
60.4–66.9), and 12.5 % (95 % CI, 9.9–15.0), respectively
(Table 3). When we stratified the analysis by partici-
pants’ age at baseline, the proportions attributable to
additive interaction were 15.9 % (95 % CI, 8.9–22.9) for
age ≤30 years, 12.9 % (95 % CI, 8.6–17.1) for 31–35
years, and 11.8 % (95 % CI, 8.0–15.6) for ≥36 years
(Table 3).
Compared to the rest of the cohort, women with birth
weight at term of 2.5–4.49 kg and all the five healthy
lifestyles had a relative risk of 0.33 (95 % CI, 0.26–0.43)
for risk of hypertension. The PAR% for not being in this
group was 66.3 %, indicating 66 % of the new cases of
hypertension in our cohort could have potentially been
prevented if they had all five healthy lifestyle factors
combined with a birth weight at term 2.5–4.49 kg
(Table 4). The PAR% for not being in the low-risk group
was 76.1 % (41.5–91.4) for those ≤30 years, 63.8 % (95 %
CI, 44.7–77.3) for 31–35 years, and 66.0 % (95 % CI,
53.7–75.6) for ≥36 years (Table 4). In addition, the
PAR% for not being in the low-risk group was 63.3 %
(95 % CI, 50.4–73.4) among women with a family history
of hypertension and 70.5 % (95 % CI, 55.6–81.0) among
women without a family history. In the sensitivity analysis,
the women with birth weight at term of 2.5–4.49 kg and
having four healthy lifestyles without considering non-
narcotic analgesics was 55.5 % (95 % CI, 48.1–62.0).
Table 2 Multivariate relative risks of hypertension according to birth weight
Term birth weight categories (kg) P trend
<2.5 2.5–3.15 3.16–3.82 3.83–4.49 ≥4.5
Cases/Person-years (PY) 510/27,436 4,077/248,172 6,330/450,509 1,541/116,911 130/11,597
Incidence rate (per 105 PY) 1,859 1,643 1,405 1,318 1,121
Age adjusted RR (95 % CI) 1.28 (1.17–1.40) 1.17 (1.13–1.22) 1.0 (ref.) 0.96 (0.91–1.02) 0.78 (0.66–0.93) <0.0001
Multivariable adjusted * 1.25 (1.14–1.37) 1.17 (1.12–1.21) 1.0 (ref.) 0.95 (0.90–1.01) 0.74 (0.62–0.88) <0.0001
Further adjusted BMI ** 1.29 (1.18–1.41) 1.20 (1.15–1.25) 1.0 (ref.) 0.90 (0.86–0.96) 0.67 (0.56–0.79) <0.0001
Multivariable adjusted relative risk estimated from Cox proportional hazards models
* Adjusted for age, ethnicity (Caucasian, yes/no), family history of hypertension (yes/no), use of oral contraceptive pills (never, past or current), smoking status (never
smoker, former smoker, current smoker: 1–14, 15–24 or ≥25 cigarettes/d), alcohol drinking (g/d: 0, 0.1–4.9, 5.0–9.9, 10.0–14.9, 15.0–29.9, and ≥30), exercise (hours/week:
0, 0.01–1.0, 1.0–3.5, 3.5–6.0, ≥6), the DASH score (quintile), supplemental folic acid intake (no, <400, 400–800 or >800 μg/d), use of aspirin or aspirin-containing products,
ibuprofen and acetaminophen (each: <1, 1, 2–3, ≥4 days/week)
** Further adjusted for body mass index (kg/m2: <21, 21–24.9, 25–29.9, 30–31.9, ≥32)
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examine potential confounding of socioeconomic status
(SES), we added self-ranking of their standing in US so-
ciety, including their money, education, and jobs, as a
surrogate of the SES to the multivariable-adjusted
model. The SES adjusted RRs of hypertension were 1.22
(95 % CI, 1.10–1.35) per 1-kg lower birth weight at term,
1.59 (95 % CI, 1.49–1.69) per 1-point higher unhealthy
lifestyle score, and 1.93 (95 % CI, 1.81–2.05) for their
joint effect, with a RERI of 0.12 (95 % CI, 0.09–0.14; P
for additive interaction <0.0001). When we applied theFig. 1 Multivariate relative risks of hypertension according to joint categories o
Unhealthy lifestyles include exercise <3.5 hours/week at moderate intensity, die
moderate alcohol consumption (moderate: 0.1–10 g alcohol/d), and use of non
adjusted relative risk estimated from Cox proportional hazards models adjusted
(never smoker, former smoker, current smoker: 1–14, 15–24, or ≥25 cigarettes/dexpanded low-risk lifestyle score, the RRs of hyperten-
sion were 1.28 (95 % CI, 1.17–1.40) per 1-kg lower birth
weight at term, 1.46 (95 % CI, 1.40–1.51) per 1-point
higher unhealthy lifestyle score (5- expanded low-risk
lifestyle score), and 1.84 (95 % CI, 1.74–1.94) for their
joint effect, with a RERI of 0.10 (95 % CI, 0.08–0.13; P
for additive interaction <0.0001). We also performed
analysis of the main research question based on the
cross-sectional data at baseline including all participants
without missing data of birth weight and lifestyle factors.
The odds ratios of hypertension were 1.09 (95 % CI,f birth weight at term and unhealthy lifestyle based on NHS2 1991–2011.
t in bottom four quintiles of the DASH score, BMI ≥25 kg/m2, not
-narcotic analgesic medications at least once per week. Multivariable
for age, ethnicity, and family history of hypertension, smoking status
), supplemental folic acid intake, and oral contraceptive use.
Table 3 Attributing effects to additive interaction between term birth weight and lifestyle on risks of hypertension*
ALL Baseline age (years)
≤30 31–35 ≥36
(n = 8,652) ** (n = 17,237) ** (n = 26,315) **
Main Effects
Lower birth weight at term (per kg) 1.23 (1.11–1.36) 1.22 (0.88–1.69) 1.25 (1.03–1.51) 1.21 (1.06–1.37)
Unhealthy lifestyle (per score) *** 1.61 (1.51–1.71) 1.73 (1.41–2.12) 1.67 (1.48–1.88) 1.55 (1.43–1.68)
Joint effect 1.95 (1.83–2.07) 2.13 (1.74–2.52) 2.05 (1.82–2.28) 1.86 (1.70–2.01)
Relative excess risk due to interaction (RERI)
RERI 0.12 (0.09–0.15) 0.18 (0.05–0.31) 0.14 (0.07–0.20) 0.10 (0.07–0.13)
P <0.0001 0.006 <0.0001 <0.0001
Attributable proportion, %
Lower birth weight at term (per kg) 23.9 (16.6–31.2) 19.3 (–2.3–40.9) 23.7 (11.1–36.2) 24.2 (14.0–34.4)
Unhealthy lifestyle 63.7 (60.4–66.9) 64.8 (55.6–74.0) 63.5 (57.8–69.2) 64.0 (59.6–68.4)
Additive interaction 12.5 (9.9–15.0) 15.9 (8.9–22.9) 12.9 (8.6–17.1) 11.8 (8.0–15.6)
* Multivariable adjusted relative risk estimated from Cox proportional hazards models adjusted for age, ethnicity (Caucasian, yes/no), family history of
hypertension (yes/no), use of oral contraceptive pills (never, past or current), smoking status (never smoker, former smoker, current smoker: 1–14, 15–24 or ≥25
cigarettes/d), and supplemental folic acid intake (no, <400, 400–800, or >800 μg/d)
** Baseline sample size
*** Unhealthy lifestyles include exercise <3.5 hours/week at moderate intensity, diet in bottom 4 quintiles of the DASH score, BMI ≥25 kg/m2, and not moderate
alcohol consumption (moderate: 1 to 10 g alcohol/d) and use of nonnarcotic analgesic medications at least once per week
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(95 % CI, 1.51–1.75) per 1-point higher unhealthy life-
style score, and 1.78 (95 % CI, 1.60–1.97) for their joint
effect, with a RERI of 0.07 (95 % CI, 0.02–0.13; P for
additive interaction of 0.005).
Discussion
After 20 years of follow-up of a large population of initially
hypertension-free young women, we observed that the risk
of hypertension associated with a combination of low birth
weight at term and unhealthy lifestyle factors was more
than the addition of the risk associated with each of these
factors, indicating a significant interaction on an additive
scale. Our data indicate that combination of a healthy
birth weight and a healthy adulthood lifestyle could pre-
vent 66 % of the cases of hypertension in this population.
It is hypothesized that restricted fetal growth reflects
maternal vascular stress inherited by her children, and
which may also interact with adulthood lifestyle [28, 29].
Even though the precise mechanisms remain unclear,
previous data have suggested that a reduced number of
nephrons associated with low birth weight might play a
pivotal role [30, 31]. A reduced nephron number may
lead to overworking or hyper-filtration of glomeruli [32],
and exacerbate the effects of other risk factors, such as a
high salt intake, on hypertension [33, 34]. Other factors
involved in the developmental programming of hyper-
tension include vascular structural and functional
changes [35], neuroendocrine adaptations to stress, insu-
lin sensitivity, and sympathetic nervous system activity
[36, 37]. To our knowledge, our study provides, for thefirst time, evidence that fetal growth restriction may
interact with later lifestyle to increase adulthood hyper-
tension risk. This finding is in line with previous obser-
vations. For example, adult blood pressure was more
markedly affected by obesity among individuals with low
birth weight [38] than normal birth weight individuals
or among individuals exposed to famine prenatally than
non-exposed individuals [10]. In our earlier analyses in a
large Chinese cohort [8], we found that the associations of
fetal famine exposure cohort with increased blood pres-
sure in adulthood appeared to be stronger among adults
who were overweight or had a Western dietary pattern in
later life. Our finding in the current study provided further
evidence that individuals with fetal growth restriction may
be more sensitive to the adverse effects of later life un-
healthy lifestyles on hypertension risk.
It is widely accepted that hypertension can be pre-
vented by lifestyle modifications. The National High
Blood Pressure Education Program Coordinating Com-
mittee published its first statement on the primary preven-
tion of hypertension in 1993 [39] and updated it in 2002
[13]. The recommended lifestyle modifications for primary
prevention of hypertension include maintaining a normal
body weight, dietary modifications, engaging in regular
aerobic physical activity, and limiting alcohol consumption
[13]. Recent meta-analyses of lifestyle-related intervention
studies provided solid evidence for the primary prevention
of hypertension by modifications of those lifestyle factors
[40, 41]. In a previous study of NHS II between 1991 and
2005 [12], a hypothetical PAR of 78 % was observed for
women who lacked the six low-risk lifestyle factors,
Table 4 Multivariate relative and hypothesized population attributable risks (PARs) of incident hypertension *,**









4: Birth weight 2.5–4.49 kg plus three healthy lifestyles
Highest DASH quintile, daily vigorous exercise, and alcohol 0.1–10 g/d 3.93 317 0.72 (0.65–0.81) 27.0 (18.9–34.7)
5: The above four factors plus BMI <25 kg/m2 2.90 156 0.44 (0.37–0.51) 55.5 (48.1–62.0)
6: The above five factors plus non-narcotic analgesic use 1.58 60 0.33 (0.26–0.43) 66.3 (56.9–74.0)
Baseline age <30 years‡
4: Birth weight 2.5–4.49 kg plus three healthy lifestyles
Highest DASH quintile, daily vigorous exercise, and alcohol 0.1–10 g/d 3.45 22 0.64 (0.42–0.98) 35.1 (6.0–58.8)
5: The above four factors plus BMI <25 kg/m2 2.59 6 0.28 (0.14–0.56) 71.4 (45.6–86.2)
6: The above five factors plus nonnarcotic analgesic use 1.58 4 0.24 (0.09–0.63) 76.1 (41.5–91.4)
Baseline age 31–35 years‡
4: Birth weight 2.5–4.49 kg plus three healthy lifestyles
Highest DASH quintile, daily vigorous exercise, and alcohol 0.1–10 g/d 3.81 93 0.79 (0.65–0.97) 20.3 (3.8–35.6)
5: The above four factors plus BMI <25 kg/m2 2.91 44 0.44 (0.33–0.59) 55.5 (41.1–67.3)
6: The above five factors plus nonnarcotic analgesic use 1.64 19 0.36 (0.23–0.56) 63.6 (44.7–77.3)
Baseline age ≥36 years‡
4: Birth weight 2.5–4.49 kg plus three healthy lifestyles
Highest DASH quintile, daily vigorous exercise, and alcohol 0.1–10 g/d 4.18 202 0.70 (0.61–0.81) 29.1 (19.1–38.4)
5: The above four factors plus BMI <25 kg/m2 2.99 104 0.46 (0.38–0.56) 53.5 (44.0–61.8)
6: The above five factors plus nonnarcotic analgesic use 1.54 37 0.34 (0.24–0.46) 66.0 (53.7–75.6)
* Relative risks compared individuals in the low-risk category with the rest of the population; Adjusted for age (in 5-year categories), time periods, presence of a
family history of hypertension, ethnicity, use of oral contraceptive pills, supplemental folic acid intake, smoking status, and the lifestyle factors that’s not included
in the subgroup categories, the five lifestyle factors included nonnarcotic analgesic use, exercise, DASH score, BMI, and alcohol consumption
** The population-attributable risk is the percentage of cases of hypertension in the population that would theoretically not have occurred if all individuals had
been in the low-risk category for these factors
‡Analysis stratified by age at baseline
Li et al. BMC Medicine  (2015) 13:175 Page 7 of 10including the five low-risk lifestyle factors included in the
current analysis and intake of 400 μg/d or more of sup-
plemental folic acid [12]. Compared to the previous
analysis, we did not include supplemental folic acid as a
low-risk lifestyle factor as the nationwide fortification
of enriched uncooked cereal grains with folic acid in
the United States became mandatory from 1998 [42];
after that, the mean serum folate level has stayed at a
much higher level [43], and thus the benefit of further
supplementation of folic acid is not clear. In the
current study, the observed PAR% for the absence of
six low-risk factors, including healthy birth weight and
five low-risk lifestyle factors, was 66 %, which is some-
what lower than the previous study [12]. One reason
for such difference is that the current cohort included
six additional years of follow-up and thus the partici-
pants became much older. When we stratified the study
population by baseline age, the PAR% for absence of
five low-risk factors and birth weight within 2.5–4.49
kg was 76 % among women who were less than 30 years
of age at baseline, which was higher than the previous
estimation of the five low-risk factors (72 %) [12]. Thedifference of PAR% across different age groups is con-
sistent with findings from our previous observation
[44] and highlights the importance of lifestyle modifica-
tions at early age.
Our study also indicates that 12 % of hypertension
cases may only occur if both unhealthy birth weight and
unhealthy lifestyle were present, not if only one or the
other is present [24]. This finding is important not only
for the primary prevention of hypertension, but also for
understanding the mechanism [45]. Specifically, a per-
centage of hypertension cases appeared to be related to
the additive effects of both prenatal and later life fac-
tors, providing new evidence in this research area [28,
29]. As low birth weight itself is not a causal factor in
the fetal programming of adult disease but an indicator
of intra-uterine adversity that increases the risk of
hypertension in adulthood, our findings emphasize the
importance of prevention of fetal growth restriction that
may be due to modifiable risk factors, such as maternal
nutrition and smoking [46, 47]. Adoption of a healthy
lifestyle by young women could not only benefit them,
but also prevent hypertension in their offspring [48].
Li et al. BMC Medicine  (2015) 13:175 Page 8 of 10A major strength of the present study is decompos-
ition of the joint effect of birth weight and adulthood
lifestyle factors. Our study, for the first time, quantita-
tively estimated the joint effects of prenatal and adult-
hood risk factors on risk of hypertension. Other
strengths of the present study include the large number
of incident hypertension cases, long-term follow-up,
and repeated measurement of lifestyle factors during
the 20 years of follow-up.
Our study has several limitations. First, our cohorts in-
cluded mostly Caucasian women and the PAR was
population-specific, which limited the generalizability to
men or other ethnic groups of women. However, the
relative homogeneity of the study populations in educa-
tional attainment and SES enhances the internal validity.
The prevalence of low-risk factors in the NHS II
women is much higher than that among Black and His-
panic women [49], while the percentage of low birth
weight [50] is greater in the general US population than
that in our cohorts. Therefore, the impact of unhealthy
lifestyle and low birth weight would be greater in more
racially diverse populations. Second, we could not ex-
clude the possibility of exposure misclassification of the
questionnaire-based assessment of lifestyle factors.
However, the prospective study design indicates such
bias would likely be random with respect to outcome
status, resulting in attenuation of the effect estimates,
thus underestimating the true associations. This study
was also limited by its reliance on self-reported birth
weight and lifestyle factors. As discussed previously
[14, 51, 52], missing birth weight or lifestyle factors was
likely to be random in our cohort, and therefore un-
likely to affect the associations we observed artefac-
tually. Although we have adjusted for family history of
hypertension, residual confounding from genetic effect
still could not be totally ruled out. Recent genome-wide
association meta-analysis identified seven loci associ-
ated with birth weight, and one of these (ADRB1) was
also associated with adult blood pressure [53]. Unmeas-
ured confounding might also exist even though we have
controlled for a wide range of risk factors for hyperten-
sion. However, only a very strong unmeasured risk
factor for hypertension together with a very large
prevalence imbalance among exposure groups could
explain our findings [54, 55].
Conclusion
In conclusion, our findings suggest that the effects of
fetal growth restriction and unhealthy lifestyle on the
risk of hypertension are greater than additive. Though
some cases of hypertension may only be prevented by
simultaneous improvement of both prenatal and postna-
tal factors, the majority of cases of hypertension could
be prevented by the adoption of a healthier lifestyle.Abbreviations
BMI: Body mass index; CI: Confidence interval; DASH: Dietary Approaches to
Stop Hypertension; FFQ: Food Frequency Questionnaire; NHS II: Nurses’
Health Study II; PAR%: Population-attributable risk; RR: Relative risk;
SES: Socioeconomic status.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YL: Conception and design, analysis and interpretation of the data, drafting
of the article, and critical revision of the article for important intellectual
content. SL: Interpretation of the data and critical revision of the article for
important intellectual content. TJV: Analysis and interpretation of the data
and critical revision of the article for important intellectual content. GCC:
Critical revision of the article for important intellectual content, provision of
study materials or patients, and collection and assembly of data. JWR: Critical
revision of the article for important intellectual content, provision of study
materials or patients, collection and assembly of data. WCW: Critical revision
of the article for important intellectual content, provision of study materials
or patients, collection and assembly of data, obtaining of funding. JPF:
Critical revision of the article for important intellectual content, provision of
study materials or patients, collection and assembly of data. FBH: Conception
and design, critical revision of the article for important intellectual content,
provision of study materials or patients, collection and assembly of data, and
obtaining of funding. LQ: Conception and design, critical revision of the
article for important intellectual content, provision of study materials or
patients, collection and assembly of data, and obtaining of funding.
All authors read and approved the final manuscript.
Sources of funding
This study was supported by grants (UM1 CA176726) from the National
Institutes of Health. Current study was supported by the National Heart,
Lung, and Blood Institute (HL071981, HL034594), the National Institute of
Diabetes and Digestive and Kidney Diseases (DK091718), the Boston Obesity
Nutrition Research Center (DK46200), and United States – Israel Binational
Science Foundation Grant 2011036. Dr. Qi was a recipient of the American
Heart Association Scientist Development Award (0730094 N).
Author details
1Department of Nutrition, Harvard School of Public Health, Boston, MA, USA.
2Department of Epidemiology, Harvard School of Public Health, Boston, MA,
USA. 3Department of Biostatistics, Harvard School of Public Health, Boston,
MA, USA. 4Channing Division of Network Medicine, Department of Medicine,
Brigham and Women’s Hospital, Harvard Medical School, 665 Huntington
Ave, Boston, MA 02115, USA. 5Renal Division, Department of Medicine,
Brigham and Women’s Hospital, Boston, MA, USA. 6The Connors Center for
Women’s Health and Gender Biology, Brigham and Women’s Hospital,
Harvard Medical School, Boston, MA, USA.
Received: 4 February 2015 Accepted: 25 June 2015
References
1. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the
United States: National Health and Nutrition Examination Survey, 2011–
2012. NCHS data brief 2013, p. 1–8. http://www.cdc.gov/nchs/data/
databriefs/db133.pdf.
2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A
comparative risk assessment of burden of disease and injury attributable to 67
risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis
for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.
3. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The
preventable causes of death in the United States: comparative risk assessment
of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6, e1000058.
4. Huxley R, Neil A, Collins R. Unravelling the fetal origins hypothesis: is there
really an inverse association between birthweight and subsequent blood
pressure? Lancet. 2002;360:659–65.
5. Huxley RR, Shiell AW, Law CM. The role of size at birth and postnatal catch-
up growth in determining systolic blood pressure: a systematic review of
the literature. J Hypertens. 2000;18:815–31.
Li et al. BMC Medicine  (2015) 13:175 Page 9 of 106. Law CM, Shiell AW. Is blood pressure inversely related to birth weight? The
strength of evidence from a systematic review of the literature. J Hypertens.
1996;14:935–41.
7. Li Y, He Y, Qi L, Jaddoe VW, Feskens EJ, Yang X, et al. Exposure to the
Chinese famine in early life and the risk of hyperglycemia and type 2
diabetes in adulthood. Diabetes. 2010;59:2400–6.
8. Li Y, Jaddoe VW, Qi L, He Y, Lai J, Wang J, et al. Exposure to the Chinese
famine in early life and the risk of hypertension in adulthood. J Hypertens.
2011;29:1085–92.
9. Li Y, Jaddoe VW, Qi L, He Y, Wang D, Lai J, et al. Exposure to the Chinese
famine in early life and the risk of metabolic syndrome in adulthood.
Diabetes Care. 2011;34:1014–8.
10. Stanner SA, Bulmer K, Andres C, Lantseva OE, Borodina V, Poteen VV, et al.
Does malnutrition in utero determine diabetes and coronary heart disease
in adulthood? Results from the Leningrad siege study, a cross sectional
study. BMJ. 1997;315:1342–8.
11. Stein AD, Zybert PA, van der Pal-de Bruin K, Lumey LH. Exposure to famine
during gestation, size at birth, and blood pressure at age 59 y: evidence
from the Dutch Famine. Eur J Epidemiol. 2006;21:759–65.
12. Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated
with incident hypertension in women. JAMA. 2009;302:401–11.
13. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary
prevention of hypertension: clinical and public health advisory from The
National High Blood Pressure Education Program. JAMA. 2002;288:1882–8.
14. Curhan GC, Chertow GM, Willett WC, Spiegelman D, Colditz GA, Manson JE,
et al. Birth weight and adult hypertension and obesity in women.
Circulation. 1996;94:1310–5.
15. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and
risk of incident hypertension among young women. Hypertension.
2008;52:828–32.
16. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, et al.
Validation of questionnaire information on risk factors and disease
outcomes in a prospective cohort study of women. Am J Epidemiol.
1986;123:894–900.
17. Troy LM, Michels KB, Hunter DJ, Spiegelman D, Manson JE, Colditz GA, et al.
Self-reported birthweight and history of having been breastfed among
younger women: an assessment of validity. Int J Epidemiol. 1996;25:122–7.
18. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A
clinical trial of the effects of dietary patterns on blood pressure. DASH
Collaborative Research Group. NEJM. 1997;336:1117–24.
19. Dauchet L, Kesse-Guyot E, Czernichow S, Bertrais S, Estaquio C, Péneau S,
et al. Dietary patterns and blood pressure change over 5-y follow-up in the
SU.VI.MAX cohort. Am J Clin Nutr. 2007;85:1650–6.
20. Curhan GC, Willett WC, Rosner B, Stampfer MJ. Frequency of analgesic use
and risk of hypertension in younger women. Arch Intern Med.
2002;162:2204–8.
21. Dedier J, Stampfer MJ, Hankinson SE, Willett WC, Speizer FE, Curhan GC.
Nonnarcotic analgesic use and the risk of hypertension in US women.
Hypertension. 2002;40:604–8. Discussion 1–3.
22. Forman JP, Stampfer MJ, Curhan GC. Non-narcotic analgesic dose and risk
of incident hypertension in US women. Hypertension. 2005;46:500–7.
23. Li R, Chambless L. Test for additive interaction in proportional hazards
models. Ann Epidemiol. 2007;17:227–36.
24. VanderWeele TJ, Asomaning K, Tchetgen Tchetgen EJ, Han Y, Spitz MR,
Shete S, et al. Genetic variants on 15q25.1, smoking, and lung cancer: an
assessment of mediation and interaction. Am J Epidemiol. 2012;175:1013–20.
25. VanderWeele TJ, Tchetgen EJ. Attributing effects to interactions.
Epidemiology. 2014;25:711–22.
26. VanderWeele TJ, Knol MJ. A tutorial on interaction. Epidemiol. Methods
2014;3:33–72.
27. Wacholder S, Benichou J, Heineman EF, Hartge P, Hoover RN. Attributable risk:
advantages of a broad definition of exposure. Am J Epidemiol. 1994;140:303–9.
28. Barker DJ. Fetal origins of coronary heart disease. BMJ. 1995;311:171–4.
29. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and
early-life conditions on adult health and disease. N Engl J Med. 2008;359:61–73.
30. Bauer R, Walter B, Bauer K, Klupsch R, Patt S, Zwiener U. Intrauterine growth
restriction reduces nephron number and renal excretory function in
newborn piglets. Acta Physiol Scand. 2002;176:83–90.
31. Hughson MD, Douglas-Denton R, Bertram JF, Hoy WE. Hypertension,
glomerular number, and birth weight in African Americans and white
subjects in the southeastern United States. Kidney Int. 2006;69:671–8.32. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients
with primary hypertension. N Engl J Med. 2003;348:101–8.
33. Nehiri T, Duong Van Huyen JP, Viltard M, Fassot C, Heudes D, Freund N,
et al. Exposure to maternal diabetes induces salt-sensitive hypertension and
impairs renal function in adult rat offspring. Diabetes. 2008;57:2167–75.
34. Salazar F, Reverte V, Saez F, Loria A, Llinas MT, Salazar FJ. Age- and sodium-
sensitive hypertension and sex-dependent renal changes in rats with a
reduced nephron number. Hypertension. 2008;51:1184–9.
35. Karatza AA, Varvarigou A. Intrauterine growth restriction and the developing
vascular tree. In: Lumey LH, Vaiserman A, editors. Early life nutrition and adult
health and development. New York: NOVA Biomedical; 2013. p. 331–52.
36. Baum M. Role of the kidney in the prenatal and early postnatal programming
of hypertension. Am J Physiol Renal Physiol. 2010;298:F235–247.
37. Luyckx VA, Bertram JF, Brenner BM, Fall C, Hoy WE, Ozanne SE, et al. Effect
of fetal and child health on kidney development and long-term risk of
hypertension and kidney disease. Lancet. 2013;382:273–83.
38. Leon DA, Koupilova I, Lithell HO, Berglund L, Mohsen R, Vagero D, et al.
Failure to realise growth potential in utero and adult obesity in relation to
blood pressure in 50 year old Swedish men. BMJ. 1996;312:401–6.
39. National High Blood Pressure Education Program Working Group report
on primary prevention of hypertension. Arch Internal Med.
1993;153:186–208.
40. Baena CP, Olandoski M, Younge JO, Buitrago-Lopez A, Darweesh SK,
Campos N, et al. Effects of lifestyle-related interventions on blood pressure
in low and middle-income countries: systematic review and meta-analysis.
J Hypertens. 2014;32:961–73.
41. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, et al.
Lifestyle interventions to reduce raised blood pressure: a systematic review
of randomized controlled trials. J Hypertens. 2006;24:215–33.
42. U.S. Food and Drug Administration. Food standards: amendment of
standards of identity for enriched grain products to require addition of folic
acid. Final rule. 21 CFR Parts 136, 137, and 139. Fed Regist 1996.
http://www.gpo.gov/fdsys/pkg/FR-1996-09-05/pdf/96-22606.pdf.
43. Pfeiffer CM, Hughes JP, Lacher DA, Bailey RL, Berry RJ, Zhang M, et al.
Estimation of trends in serum and RBC folate in the U.S. population from
pre- to postfortification using assay-adjusted data from the NHANES
1988–2010. J Nutr. 2012;142:886–93.
44. Cohen L, Curhan GC, Forman JP. Influence of age on the association
between lifestyle factors and risk of hypertension. J Am Soc Hypertens.
2012;6:284–90.
45. VanderWeele TJ, Robins JM. The identification of synergism in the sufficient-
component-cause framework. Epidemiol. 2007;18:329–39.
46. Persson LA, Arifeen S, Ekstrom EC, Rasmussen KM, Frongillo EA, Yunus M.
Effects of prenatal micronutrient and early food supplementation on
maternal hemoglobin, birth weight, and infant mortality among children in
Bangladesh: the MINIMat randomized trial. JAMA. 2012;307:2050–9.
47. Ko TJ, Tsai LY, Chu LC, Yeh SJ, Leung C, Chen CY, et al. Parental smoking
during pregnancy and its association with low birth weight, small for
gestational age, and preterm birth offspring: a birth cohort study. Pediatr
Neonatol. 2014;55:20–7.
48. de Jonge LL, Harris HR, Rich-Edwards JW, Willett WC, Forman MR, Jaddoe
VW, et al. Parental smoking in pregnancy and the risks of adult-onset
hypertension. Hypertension. 2013;61:494–500.
49. Schoenborn CA, Adams PF. Health behaviors of adults: United States,
2005–2007. Vital Health Stat 10. 2010;245:1–132.
50. U.S. Department of Health and Human Services, Health Resources and
Services Administration, Maternal and Child Health Bureau. Child Health
USA 2013. Rockville, Maryland: U.S. Department of Health and Human
Services, 2013. http://mchb.hrsa.gov/publications/pdfs/childhealth2013.pdf.
Accessed 23 May 2015.
51. Rich-Edwards JW, Colditz GA, Stampfer MJ, Willett WC, Gillman MW,
Hennekens CH, et al. Birthweight and the risk for type 2 diabetes mellitus in
adult women. Ann Intern Med. 1999;130:278–84.
52. Rich-Edwards JW, Kleinman K, Michels KB, Stampfer MJ, Manson JE, Rexrode
KM, et al. Longitudinal study of birth weight and adult body mass index in
predicting risk of coronary heart disease and stroke in women. BMJ.
2005;330:1115.
53. Horikoshi M, Yaghootkar H, Mook-Kanamori DO, Sovio U, Taal HR, Hennig
BJ, et al. New loci associated with birth weight identify genetic links
between intrauterine growth and adult height and metabolism. Nat Genet.
2013;45:76–82.
Li et al. BMC Medicine  (2015) 13:175 Page 10 of 1054. Schneeweiss S. Sensitivity analysis and external adjustment for unmeasured
confounders in epidemiologic database studies of therapeutics.
Pharmacoepidemiol Drug Saf. 2006;15:291–303.
55. Lee WC. Bounding the bias of unmeasured factors with confounding and
effect-modifying potentials. Stat Med. 2011;30:1007–17.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
